CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

PIK3CA mutation

Gene: PIK3CA · Type: mutation

Indications: Breast cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
AlpelisibBreast cancerINDICATED
FDA CDx
Label
CapivasertibBreast cancerINDICATED
FDA Label
Label
InavolisibBreast cancerINDICATED
FDA Label
Label